Cargando…
TFEB Rearranged Renal Cell Carcinoma: Pathological and Molecular Characterization of 10 Cases, with Novel Clinical Implications: A Single Center 10-Year Experience
To report our experience with the cases of TFEB rearranged RCC, with particular attention to the clinicopathological, immunohistochemical and molecular features of these tumors and to their predictive markers of response to therapy. We have retrieved the archives of 9749 renal cell carcinomas in the...
Autores principales: | Wang, Ai-Xiang, Tian, Tai, Liu, Li-Bo, Yang, Feng, He, Hui-Ying, Zhou, Li-Qun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9952947/ https://www.ncbi.nlm.nih.gov/pubmed/36830782 http://dx.doi.org/10.3390/biomedicines11020245 |
Ejemplares similares
-
TFE3 and TFEB-rearranged renal cell carcinomas: an immunohistochemical panel to differentiate from common renal cell neoplasms
por: Caliò, Anna, et al.
Publicado: (2022) -
mTOR-dependent TFEB activation and TFEB overexpression enhance autophagy-lysosome pathway and ameliorate Alzheimer's disease-like pathology in diabetic encephalopathy
por: Cheng, Lizhen, et al.
Publicado: (2023) -
Functional TFEB activation characterizes multiple models of renal cystic disease and loss of polycystin-1
por: Shillingford, Jonathan M., et al.
Publicado: (2023) -
Celastrol enhances transcription factor EB (TFEB)-mediated autophagy and mitigates Tau pathology: Implications for Alzheimer's disease therapy
por: Yang, Chuanbin, et al.
Publicado: (2022) -
A splicing variant of TFEB negatively regulates the TFEB-autophagy pathway
por: Park, Jee-Yun, et al.
Publicado: (2021)